BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32453263)

  • 1. Pharmacogenomics of thiopurines: distribution of TPMT and NUDT15 polymorphisms in the Brazilian Amazon.
    Ferreira GMA; Ribeiro Elias AB; Nascimento J; Monteiro WM; Melo GC; Baia-da-Silva DC; Lacerda MVG; Suarez-Kurtz G
    Pharmacogenet Genomics; 2020 Oct; 30(8):184-189. PubMed ID: 32453263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogeomic implications of population diversity in Latin America: TPMT and NUDT15 polymorphisms and thiopurine dosing.
    Suarez-Kurtz G; Araújo GS; de Sousa SJ
    Pharmacogenet Genomics; 2020 Jan; 30(1):1-4. PubMed ID: 31651720
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Perini JA; Basta PC; Suarez-Kurtz G
    Front Pharmacol; 2024; 15():1359570. PubMed ID: 38379902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azathioprine dose tailoring based on pharmacogenetic information: Insights of clinical implementation.
    Díaz-Villamarín X; Fernández-Varón E; Rojas Romero MC; Callejas-Rubio JL; Cabeza-Barrera J; Rodríguez-Nogales A; Gálvez J; Morón R
    Biomed Pharmacother; 2023 Dec; 168():115706. PubMed ID: 37857254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update.
    Relling MV; Schwab M; Whirl-Carrillo M; Suarez-Kurtz G; Pui CH; Stein CM; Moyer AM; Evans WE; Klein TE; Antillon-Klussmann FG; Caudle KE; Kato M; Yeoh AEJ; Schmiegelow K; Yang JJ
    Clin Pharmacol Ther; 2019 May; 105(5):1095-1105. PubMed ID: 30447069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotyping NUDT15*3 rs1166855232 reveals higher frequency of potential adverse effects of thiopurines in Natives and Mestizos from Mexico.
    Texis T; Guzmán-Cruz C; Rodríguez-Dorantes M; Sánchez-García S; Mino-León D; Gonzalez-Covarrubias V
    Pharmacol Rep; 2022 Feb; 74(1):257-262. PubMed ID: 34091879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of polymorphisms in thiopurine metabolism and association with adverse outcomes: a South Asian region-specific systematic review and meta-analysis.
    Jena A; Jha DK; Kumar-M P; Kasudhan KS; Kumar A; Sarwal D; Mishra S; Singh AK; Bhatia P; Patil A; Sharma V
    Expert Rev Clin Pharmacol; 2021 Apr; 14(4):491-501. PubMed ID: 33682590
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of genetic polymorphism of TPMT and NUDT15 on the tolerance of 6-mercaptopurine therapy in adult acute lymphoblastic leukemia].
    Hao QS; Wang Z; Fang QY; Gong XY; Liu KQ; Li Y; Wei H; Wang Y; Li QH; Wang M; Tian Z; Wang JX; Mi YC
    Zhonghua Xue Ye Xue Za Zhi; 2021 Nov; 42(11):911-916. PubMed ID: 35045652
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictive role of NUDT15 variants on thiopurine-induced myelotoxicity in Asian inflammatory bowel disease patients.
    Sutiman N; Chen S; Ling KL; Chuah SW; Leong WF; Nadiger V; Tjai M; Choon Kong CS; Schwender BJ; Chan W; Shim HH; Lim WC; Khor CC; Cheung YB; Chowbay B
    Pharmacogenomics; 2018 Jan; 19(1):31-43. PubMed ID: 29210335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The c.415C>T polymorphism in NUDT15 is more frequent than the polymorphisms in TPMT in Chilean patients who use thiopurine drugs.
    von Muhlenbrock C; Estay C; Covarrubias N; Miranda J; Venegas M
    Pharmacogenet Genomics; 2023 Sep; 33(7):161-163. PubMed ID: 37556121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NUDT15 C415T variant compared with TPMT genotyping in predicting azathioprine-induced leucopenia: prospective analysis of 1014 inflammatory bowel disease patients in India.
    Banerjee R; Ravikanth VV; Pal P; Bale G; Avanthi US; Goren I; Girish BG; Mitnala S; Reddy DN
    Aliment Pharmacol Ther; 2020 Dec; 52(11-12):1683-1694. PubMed ID: 33111378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Pharmacogenomics in the Efficacy and Safety of Thiopurines in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Gutiérrez-Valencia M; Leache L; Saiz LC; Beloqui JJ; Barajas M; Vicuña M; Erviti J
    J Clin Gastroenterol; 2023 Aug; 57(7):671-685. PubMed ID: 36322453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preemptive NUDT15 genotyping: redefining the management of patients with thiopurine-induced toxicity.
    Shah SAV; Paradkar MU; Desai DC; Ashavaid TF
    Drug Metab Pers Ther; 2018 Mar; 33(1):57-60. PubMed ID: 29470173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of NUDT15 genetics on severe thiopurine-related hematotoxicity in patients with European ancestry.
    Schaeffeler E; Jaeger SU; Klumpp V; Yang JJ; Igel S; Hinze L; Stanulla M; Schwab M
    Genet Med; 2019 Sep; 21(9):2145-2150. PubMed ID: 30728528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TPMT and NUDT15 polymorphisms in thiopurine induced leucopenia in inflammatory bowel disease: a prospective study from India.
    Grover N; Bhatia P; Kumar A; Singh M; Lad D; Mandavdhare HS; Samanta J; Prasad KK; Dutta U; Sharma V
    BMC Gastroenterol; 2021 Aug; 21(1):327. PubMed ID: 34425754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TPMT and NUDT15 Variants Predict Discontinuation of Azathioprine for Myelotoxicity in Patients with Inflammatory Disease: Real-World Clinical Results.
    Dickson AL; Daniel LL; Zanussi J; Dale Plummer W; Wei WQ; Liu G; Reese T; Anandi P; Birdwell KA; Kawai V; Cox NJ; Dupont WD; Hung AM; Feng Q; Stein CM; Chung CP
    Clin Pharmacol Ther; 2022 Jan; 111(1):263-271. PubMed ID: 34582038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of genetic variants in TPMT, ITPA, and NUDT15 with azathioprine-induced myelosuppression in southwest china patients with autoimmune hepatitis.
    Miao Q; Yan L; Zhou Y; Li Y; Zou Y; Wang L; Bai Y; Zhang J
    Sci Rep; 2021 Apr; 11(1):7984. PubMed ID: 33846471
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Yang J; Wang P; Qin Z; Jia M; Zhang C; Tian X; Zheng Y; Zhang A; Zhang X; Liu S
    Genet Test Mol Biomarkers; 2019 Oct; 23(10):751-757. PubMed ID: 31556692
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of
    Wang HH; He Y; Wang HX; Liao CL; Peng Y; Tao LJ; Zhang W; Yang HX
    World J Gastroenterol; 2018 Feb; 24(8):941-948. PubMed ID: 29491687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetic determinants of thiopurines in an Indian cohort.
    Naushad SM; Janaki Ramaiah M; Kutala VK; Hussain T; Alrokayan SA
    Pharmacol Rep; 2021 Feb; 73(1):278-287. PubMed ID: 32935219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.